atau cari berdasarkan hari
The Indonesian government decided to pause the use and distribution of the CTMAV547 batch of AstraZeneca vaccine.
Health Ministry announced that the vaccination program utilizing the AstraZeneca vaccine will continue as planned.
Komnas KIPI said there was not enough evidence about the effect of the AstraZeneca vaccine on Trio Fauqi Firdaus.
Indonesia received the third batch of ready-to-use COVID-19 vaccine developed by AstraZeneca, under the COVAX facility multilateral scheme.
Jakarta Government confirmed it had drafted regulations for administering AstraZeneca vaccines as part of the capital's Covid-19 immunization program.
1.5 million doses of AstraZeneca vaccines will be distributed to the capital city's healthcare facilities.
Bio Farma prepares up to 18 million doses of Covid-19 vaccine for May 2021 which comes from the 59.5 million Sinovac bulk doses.
A total of 11,981,034 Indonesians have been administered the COVID-19 vaccine as of Tuesday, according to the Task Force for COVID-19 Handling.
President Joko "Jokowi" Widodo urged all parties to work hard to prevent a new wave of Covid-19 as occurred in a number of countries.
Indonesia on Monday received 3.852 million ready-to-use COVID-19 vaccine doses developed by AstraZeneca.
The second batch of COVID-19 vaccine from the COVAX facility has finally arrived in Indonesia.
The Health Ministry's spokesperson for Covid-19 vaccination confirmed that 3,852,000 doses of the AstraZeneca vaccine will arrive in early May 2021.
Health Minister Budi Gunadi confirmed that the Covid-19 vaccine stock for April and May is sufficient amid concerns that it might be disrupted.
Australia reported its first fatality from blood clots in a recipient of AstraZeneca's COVID-19 shot.
Europe's vaccine rollout hit more trouble on Wednesday, after U.S. drugmaker Johnson & Johnson delayed its COVID-19 shot.
Johnson & Johnson says it is aware of the rare reports of blood clots in individuals given its COVID-19 vaccine.
The BPOM in today's House hearing announces 5 Covid-19 vaccines that are awaiting emergency use authorization (EUA) approval.
Australia launched mass vaccinations for its 25 million people in February, with most expected to receive the University of Oxford/AstraZeneca vaccine
British regulators on Thursday say they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine.
India's drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date.